期刊文献+

尼莫地平联合多奈派齐治疗轻中度血管性痴呆58例疗效观察 被引量:7

暂未订购
导出
摘要 目的观察尼莫地平联合多奈派齐治疗轻中度血管性痴呆的疗效。方法将116例轻中度血管性痴呆患者随机分为两组:观察组58例,采用尼莫地平联合多奈派齐治疗;对照组58例,采用多奈派齐治疗;疗程18周。比较两组患者的治疗效果。结果治疗后18周,两组患者MMSE、ADL评分均比治疗前明显提高,差异有统计学意义(P<0.05);观察组ADL评分高于对照组,差异有统计学意义(P<0.05)。结论尼莫地平联合多奈派齐治疗轻中度血管性痴呆的疗效优于单用多奈派齐治疗。
作者 赵大伟 刘宇
出处 《内科》 2012年第2期131-132,共2页 Internal Medicine
  • 相关文献

参考文献5

二级参考文献11

  • 1王耀山.痴呆的治疗和预防[J].实用内科杂志,1993,13(6):334-336. 被引量:14
  • 2王爱娜,苏维国.尼莫地平注射液[J].中国新药杂志,1996,5(5):341-342. 被引量:15
  • 3高素荣.痴呆诊断学[M].北京:北京科技出版社,1995.81-88.
  • 4Roman GC. Vascular dementia may be the most common form of dementia in the elderly[J]. J Neurol Sci, 2002, 204(1) :7-10.
  • 5Wentzel C, Rockwood K, Mackrrisht C, et al. Progression of impairment in patients with vascular cognitive impairment without dementia[J]. Neurology,2001,57(4) :714-716.
  • 6Lindeboom J, Weinstein H. Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer' s disease, and vascular cognitive impairment[ J ]. Eur J Pharmacol, 2004,490 ( 1-3 ) : 83- 86.
  • 7Posner HB, Tang MX, Luehsinger J, et al. The relationsMp of hypertension in the elderly to AD, vascular dementia, and cognitive function[J]. Neurology, 2002,58 ( 8 ) : 1175-1181.
  • 8[1]Hachinki VC,Hiff LD,Zihka E,et al.Cerebral blood flow in dementia[J].Archneural,1975,32(9):632~632
  • 9[4]Roman GC.Vascular dementia:distinguishing characteristies,treatment,and prevention[J].J Am Geriatr Soc,2003,51(5):296~304
  • 10周伟,吴永斌,许贤瑞.脑心通胶囊治疗血管性痴呆患者临床观察[J].山东医药,2009,49(8):99-100. 被引量:6

共引文献35

同被引文献52

  • 1赵仁亮,谭纪萍,秦海强,王桂红,王拥军.2006年NINDS/CNS关于血管性认知功能障碍统一标准的建议[J].中国卒中杂志,2007,2(6):513-521. 被引量:51
  • 2李豪侠.神经节苷酯GM1联合多奈哌齐治疗血管性痴呆临床观察[J].浙江医学,2007,29(7):765-767. 被引量:10
  • 3温洪波,张振馨,牛富生,李凌.北京地区蒙特利尔认知量表的应用研究[J].中华内科杂志,2008,47(1):36-39. 被引量:359
  • 4Nade VS, Kawale LA, Dwivedi S, et al. Neuroprotective effect of Hibiscus rosa sinensis in an oxidative stress model of cerebral post- ischemic reperfusion injury in rats[J]. Pharm Biol,2010,48 (7): 822 - 827.
  • 5Huang BR, Chang PC, Yeh WL, et al. Anti - neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells: implications for neuroprotection[J]. PLoS One,2014,9(3): e91 167.
  • 6Gareri P, Castagna A, Cotroneo AM, et al. The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives[J]. Clin Interv Aging, 2015,10:1 421 -1 429.
  • 7VORONKOVA K V IMELESHKOV M N. Use of noben (idebenone)] in the treatment of dementia and memory impairments without de1 mentia[ J]. Neurosci Sehav Physiol!2009,39(5):501-506. ].
  • 8NADE V S, KAWALE L A, DWIVEDI S, et al. Neuroproteetive effect of Hibiscus rosa sinensis in an oxidative stress model of cerebral post- ischemic reperfusion injury in rats [ J J. Pharm Biol, 2010,48 ( 7 ) : 822 -827.
  • 9HUANG B R,CHANG P C ,YEH W L,et al. Anti-neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells : implications for neuroprotection [ J ]. PLoS One, 2014,9 ( 3 ) : e91167.
  • 10ABDELAZIM S A,DARWISH H A, ALl S A, et al. Potential antifi- brotic and angiostatic impact~of idebenone, carnosine and vitamin E in nano-sized titanium dioxide-induced liver injury [ J ]. Cell Physiol Bioehem,2015,35 (6) :2402-2411.

引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部